KatzensteinAL, MyersJL. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med1998;157(4 Pt 1):1301–1315.
2.
KondohY, TaniguchiH, KawabataY, YokoiT, SuzukiK, TakagiK.Acute exacerbation in idiopathic pulmonary fibrosis: analysis of clinical and pathologic findings in three cases. Chest1993;103(6):1808–1812.
3.
AkiraM, HamadaH, SakataniM, KobayashiC, NishiokaM, YamamotoS.CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis. AJR Am J Roentgenol1997;168(1):79–83.
OlsonJ, ColbyTV, ElliottCG. Hamman-Rich syndrome revisited. Mayo Clin Proc1990;65(12):1538–1548.
9.
JantzMA, SahnSA. Corticosteroids in acute respiratory failure. Am J Respir Crit Care Med1999;160(4):1079–1100.
10.
MeduriGU, HeadleyS, TolleyE, ShelbyM, StentzF, PostlethwaiteA.Plasma and BAL cytokine response to corticosteroid rescue treatment in late ARDS. Chest1995;108(5):1315–1325.
11.
MeduriGU, TolleyEA, ChinnA, StentzF, PostlethwaiteA.Procollagen types I and III amino-terminal propeptide levels during acute respiratory distress syndrome and in response to methylprednisolone treatment. Am J Respir Crit Care Med1998;158(5 Pt 1):1432–1441.
12.
HesterbergTW, LastJA. Ozone-induced acute pulmonary fibrosis in rats: prevention of increased rates of collagen synthesis by methyl-prednisolone. Am Rev Respir Dis1981;123(1):47–52.
13.
HakkinenPJ, SchmoyerRL, WitschiHP. Potentiation of butylated-hydroxytoluene-induced acute lung damage by oxygen: effects of prednisolone and indomethacin. Am Rev Respir Dis1983;128(4):648–651.
14.
KehrerJP, Klein-SzantoAJP, SorensenEMB, PearlmanR, RosnerMH. Enhanced acute lung damage following corticosteroid treatment. Am Rev Respir Dis1984;130(2):256–261.
